Author

M. P. Jogalekar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Ashworth· 1 shared C.-L. Tsou· 1 shared G. J. Correy· 1 shared G. R. Kimmerly· 1 shared I. P. Chen· 1 shared J. S. Fraser· 1 shared L. Martinez-Sobrido· 1 shared M. Diolaiti· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Ashworth

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication and pathogenesis in vivo

T. Y. Taha, R. K. Suryawanshi, I. P. Chen, G. J. Correy, P. C. O'Leary, M. P. Jogalekar, M. McCavitt-Malvido, M. Diolaiti, G. R. Kimmerly, C.-L. Tsou, L. Martinez-Sobrido, N. J. Krogan, A. Ashworth, J. S. Fraser, M. Ott

This study shows that mutating the SARS-CoV-2 NSP3 Mac1 domain reduces viral replication and pathogenesis in vivo.

bioRxiv · Apr 18, 2023 · PreprintMicrobiology